Filter
53
Text search:
genotypic
testing
Featured
Recommendations
10
New Publications
9
Language
Document type
No document type
22
Guidelines
16
Studies & Reports
12
Strategic & Response Plan
2
Manuals
1
Countries / Regions
Western and Central Europe
2
Africa
2
India
1
Kenya
1
Malawi
1
Mozambique
1
Benin
1
Lesotho
1
Myanmar / Burma
1
Eastern Europe and Central Asia
1
Asia
1
Eastern Europe
1
Russia
1
Estonia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
12
Countries
9
Pharmacy & Technologies
3
Public Health
2
Women & Child Health
1
Toolboxes
TB
18
HIV
11
AMR
5
NTDs
4
Rapid Response
2
COVID-19
2
2.0 Rapid Response
2
Polio
1
Natural Hazards
1
Refugee
1
Mental Health
1
Caregiver
1
Pharmacy
1
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide i
...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it
...
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im
...
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen
...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg
...
Stenotrophomonas maltophiliais a nonfermenting Gram-negative rod that is ubiquitous in nature (predominantly occurring in aquatic environments and on plants). Biochemically, it iscatalase positive and oxidase negative, and it produces acid frommaltose (hence the name“maltophilia”). Due to it
...
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
